Home › Diseases, disorders & medical disciplines
Washington Institute for Coagulation
Also known as Washington Center for Bleeding Disorders
Washington Institute for Coagulation reported $112.7 million in revenue and $101.7 million in expenses for the fiscal year ending June 30, 2025. Of every $100 it spent, $97.53 went to program services, $2.47 to management and general costs and $0.00 to fundraising. Its largest source of revenue was program service revenue such as fees, sales and contracts: 98.3% of the total. The highest compensation it reported for one person was $368,948 (EXECUTIVE/MEDICAL DIRECTOR). 16 people received more than $100,000 in reportable compensation. Revenue rose 383% between 2020 and FY2025. Source: Form 990, FY2025.
Where $100 of spending went
The fiscal year ending June 30, 2025 · Form 990, Part IX, line 25 · total expenses $102MFor context, the median across 314 covered diseases, disorders & medical disciplines charities: $88.73 programs, $10.89 management, $0.38 fundraising (medians computed separately, so they may not sum to $100).
Where $100 of revenue came from
The fiscal year ending June 30, 2025 · Form 990, Part VIII · total revenue $113MThe 990 scorecard · same measures for every charity, no grades
| Measure | FY2025 | Median |
|---|---|---|
| Program services Part IX 25(B) ÷ 25(A) | 97.5% | 86.7% |
| Management & general Part IX 25(C) ÷ 25(A) | 2.5% | 10.6% |
| Fundraising Part IX 25(D) ÷ 25(A) | 0.0% | 0.4% |
| Fundraising cost per $1 of contributions Part IX 25(D) ÷ Part VIII 1h | Not reported | $0.03 |
| Contributions & grants share of revenue Part VIII 1h ÷ 12 | 0.1% | 24.7% |
| Government grants share of revenue Part VIII 1e ÷ 12 | 0.1% | 0.6% |
| Program service revenue share Part VIII 2g ÷ 12 | 98.3% | 59.5% |
| Highest reported compensation Part VII-A, columns D–F | $368,948 | $391,657 |
| Highest compensation as share of expenses Part VII-A ÷ Part IX 25(A) | 0.36% | 1.45% |
| People paid over $100,000 Part VII, line 2 | 16 | 10 |
| Net assets, in months of expenses Part X 33(B) ÷ monthly expenses | 7.7 | 7.6 |
| Independent voting board members Part VI 1a–1b | 6 of 8 | 100.0% |
A median is context, not a target: hospitals, universities, food banks and grantmakers spend in very different ways. What these measures can and can't tell you.
What the money paid for, in its own words
FY2025 · Form 990, Part III · the three largest programs by expenseClinical services: as a recognized hemophilia treatment center and acenter of excellence, we are committed to the wellbeing of patientswith an inherited bleeding disorder across the state of washington,neighboring states, and alaska. We are dedicated to refined diagnosisand assessment, secure access to therapies and comprehensivetreatment planning and readily available consultation. We strive tofoster our patients' autonomy to safely care for their disorder andcause minimal disruption to their lives. A multidisciplinary team ofhealth-care professionals addresses concerns including…
Pharmacy services: as an integral part of our comprehensive caremodel, our pharmacy provides blood clotting factor products topatients and hospital providers throughout the state of washingtonand parts of alaska, montana, and idaho. Pharmacy services at thewashington center for bleeding disorders (wacbd) has two primarycomponents, a licensed hemophilia specialty pharmacy, and a licensedpharmaceutical wholesaler. The hemophilia specialty pharmacysupports clinical operations for more than 550 adult patients whoreceive care at our main facility in seattle, wa and at outreach clinicsthroughout…
Highest reported compensation
FY2025 · Form 990, Part VII, Section A · roles as filed; names are in the filing, not here| Role | From this org | From related orgs | Other | Total |
|---|---|---|---|---|
| EXECUTIVE/MEDICAL DIRECTOR Director/trustee, officer, 40.00 hrs/week | $297,961 | $0 | $70,987 | $368,948 |
| CFO/COO (THRU 11/24)/BOARD TREASURER Director/trustee, officer, 40.00 hrs/week | $183,716 | $0 | $23,680 | $207,396 |
| PHARMACY DIRECTOR Key employee, 40.00 hrs/week | $174,064 | $0 | $31,989 | $206,053 |
| CLINICAL NURSE MANAGER Highest compensated employee, 40.00 hrs/week | $150,207 | $0 | $32,465 | $182,672 |
| CLINICAL PHARMACIST Highest compensated employee, 40.00 hrs/week | $155,485 | $0 | $20,312 | $175,797 |
| NURSE PRACTITIONER Highest compensated employee, 40.00 hrs/week | $141,912 | $0 | $27,962 | $169,874 |
| CONTROLLER Highest compensated employee, 40.00 hrs/week | $145,335 | $0 | $15,632 | $160,967 |
| CLINICAL PHARMACIST Highest compensated employee, 40.00 hrs/week | $141,860 | $0 | $11,634 | $153,494 |
16 people received more than $100,000 in reportable compensation from Washington Institute for Coagulation (Part VII, line 2). Compensation of current officers, directors and key employees totaled $809K (Part IX, line 5).
6 filings since 2020
Form 990, Parts I, VII, IX and X · each row is that year's own filing, linkedGovernance answers, as filed
FY2025 · the organization's own yes/no answers; explanations, if any, are in Schedule O of the filing · what each means- Voting board members, and how many are independent Part VI, lines 1a–1b8 · 6 independent
- Audited financial statements Part XII 2bYes
- Conflict-of-interest policy Part VI 12aYes
- Whistleblower policy Part VI 13Yes
- Document retention policy Part VI 14No
- Independent process for top executive pay Part VI 15aNo
- Board given the 990 before filing Part VI 11aYes
- Family or business ties among insiders Part VI 2No
- Aware of a significant diversion of assets Part VI 5No
- Excess benefit transaction with an insider Part IV 25aNo
- Loans to or from insiders outstanding Part IV 26No
- Lobbying, or a 501(h) election in effect Part IV 4No
- Over $15,000 of professional fundraising services Part IV 18No
- Over $10,000 of activity outside the U.S. Part IV 14bNo
- Employees Part I, line 555
- Volunteers Part I, line 66
Largest outside contractors
FY2025 · Form 990, Part VII, Section B · businesses only| UNIVERSITY OF WASHINGTON Clinical services | $1,935,466 |
| ISOUTSOURCE It professional services | $541,753 |
| VENTURE GENERAL CONTRACTING Contruction services | $268,766 |
| MULTICARE MARY BRIDGE CHILDREN'S HOSPITA Medical staffing | $243,262 |
| SEATTLE CHILDREN'S HOSPITAL Medical staffing | $237,988 |
Individuals listed as contractors are left out. 7 contractors were paid more than $100,000 in all.
Correct a figure or respond
Every number above is copied from Washington Institute for Coagulation's own Form 990. If one doesn't match the filing, that's our error and we'll fix it. If you work for Washington Institute for Coagulation, you can publish a response that is linked from this page.
Share or embed this breakdown
Of every $100 Washington Institute for Coagulation spent in FY2025, $97.53 went to programs. The full breakdown, from its IRS Form 990:
Embed on your site
Similar-sized charities in this cause
- American Society of HematologyWashington, DC · revenue $112M · programs 80.2% · FY2025
- Children's Anesthesiology Associates LtdPhiladelphia, PA · revenue $116M · programs 87.9% · FY2025
- Vivent HealthMilwaukee, WI · revenue $109M · programs 74.3% · FY2025
- Michigan Health Endowment FundBrighton, MI · revenue $116M · programs 93.3% · 2024
- The American Board of Internal MedicinePhiladelphia, PA · revenue $108M · programs 77.4% · FY2025
All diseases, disorders & medical disciplines charities · Largest charities in Washington
Questions people ask
How much of Washington Institute for Coagulation's spending goes to programs?
In the fiscal year ending June 30, 2025, Washington Institute for Coagulation reported that 97.5% of its $101.7 million in expenses went to program services, 2.5% to management and general and 0.0% to fundraising (Form 990, Part IX).
How much does Washington Institute for Coagulation pay its top executive?
The largest total compensation Washington Institute for Coagulation reported for one person in the fiscal year ending June 30, 2025 was $368,948, for the role of EXECUTIVE/MEDICAL DIRECTOR (Form 990, Part VII, including compensation from related organizations and other compensation).
Where does Washington Institute for Coagulation get its money?
Of $112.7 million in revenue in the fiscal year ending June 30, 2025, 0.1% came from contributions and grants (including 0.1% from government grants) and 98.3% from program service revenue (Form 990, Part VIII).
Is Washington Institute for Coagulation a registered charity?
The IRS lists EIN 83-2302258 as a 501(c)(3) organization (publicly supported organization (509(a)(2))), and its records show contributions as tax-deductible. Form 990 filings on record here cover tax years 2020, 2021, 2022, 2023, 2024. A filing shows what the organization reported; it doesn't by itself show whether a program works.
Sources
- FY2025: Form 990 for the fiscal year ending June 30, 2025, object 202611279349303671 · read the filing · XML
- FY2024: Form 990 for the fiscal year ending June 30, 2024, object 202521329349305507 · read the filing
- FY2023: Form 990 for the fiscal year ending June 30, 2023, object 202431359349312183 · read the filing
- FY2022 (6 mo.): Form 990 for the 6-month short period ending June 30, 2022, object 202311359349309301 · read the filing
- 2021: Form 990 for calendar year 2021, object 202203199349315545 · read the filing
- 2020: Form 990 for calendar year 2020, object 202123189349300627 · read the filing
All filings for EIN 83-2302258: ProPublica Nonprofit Explorer · IRS Tax Exempt Organization Search. Figures are as the organization reported them; we have not audited them.